Study of NM8074 in Patients with Anti-Neutrophil Cytoplasmic Antibody (ANCA)-Associated Vasculitis (AAV)

NCT06226662 · clinicaltrials.gov ↗

PHASE2

Phase

NOT_YET_RECRUITING

Status

12

Enrollment

INDUSTRY

Sponsor class

Conditions

Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis

Interventions

DRUG: NM8074
DRUG: Placebo

Sponsor

NovelMed Therapeutics